Preclinical Characterization of Naturally Occurring Polyketide Cyclophilin Inhibitors from the Sanglifehrin FamilyMatthew A. Gregory, Barrie Wilkinson, Philippe Gallay et al.|Antimicrobial Agents and Chemotherapy|2011Cited by 54
Sangamides, a new class of cyclophilin-inhibiting host-targeted antivirals for treatment of HCV infectionSteven J. Moss, Matthew A. Gregory, Michael Bobardt et al.|MedChemComm|2011Cited by 26
789 PRECLINICAL CHARACTERIZATION OF NOVEL CYCLOPHILIN INHIBITORS BASED ON THE POLYKETIDE, SANGLIFEHRINSteven J. Moss, Matthew A. Gregory, Michael Bobardt et al.|Journal of Hepatology|2011Cited by 0